Ovid Therapeutics Inc. Human Resources Contracts & Agreements
26 Contracts & Agreements
- Bonus & Incentive Agreements (10 contracts)
- Compensation Agreements (3)
- Consulting Agreements (1)
- Employment Agreements (12)
- Amended and Restated Executive Employment Agreement, dated September 9, 2024, between Ovid Therapeutics Inc. and Margaret Alexander (Filed With SEC on September 11, 2024)
- Non-Employee Director Compensation Policy, effective May 5, 2022 (Filed With SEC on May 10, 2022)
- Non-Employee Director Compensation Policy, effective May 6, 2021 (Filed With SEC on November 10, 2021)
- Amended and Restated Executive Employment Agreement between the Company and Jeffrey Rona, effective June 2, 2021 (Filed With SEC on August 16, 2021)
- Amended and Restated Executive Employment Agreement between the Company and Thomas Perone, effective January 1, 2020 (Filed With SEC on March 15, 2021)
- Executive Employment Agreement between the Company and Jason Tardio, effective October 21, 2019 (Filed With SEC on March 15, 2021)
- Executive Employment Agreement between the Company and Jeff Rona, effective September 30, 2020 (Filed With SEC on March 15, 2021)
- Third Amended and Restated Executive Employment Agreement between the Company and Tim Daly, effective December 18, 2019 (Filed With SEC on March 11, 2020)
- Second Amended and Restated Executive Employment Agreement between the Company and Amit Rakhit, effective November 1, 2019 (Filed With SEC on March 11, 2020)
- Non-Employee Director Compensation Plan (Filed With SEC on March 11, 2020)
- Separation and Consulting Agreement, by and between the Company and Matthew During, dated as of March 24, 2019 (Filed With SEC on May 7, 2019)
- Amended and Restated Executive Employment Agreement between the Registrant and Yaron Werber (Filed With SEC on May 8, 2018)
- Amended and Restated Executive Employment Agreement between the Registrant and Matthew During (Filed With SEC on May 8, 2018)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2017)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2017)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2017)
- OVID THERAPEUTICS INC. STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) (Filed With SEC on April 18, 2017)
- OVID THERAPEUTICS INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 2017 APPROVED BYTHE STOCKHOLDERS: , 2017 IPODATE: , 2017 (Filed With SEC on April 18, 2017)
- OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on April 10, 2017)
- OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT EARLY EXERCISE (Filed With SEC on April 10, 2017)
- OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN RESTRICTED STOCK PURCHASE AGREEMENT (Filed With SEC on April 10, 2017)
- AMENDMENT TO OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on April 10, 2017)
- AMENDMENT TO OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on April 10, 2017)
- AMENDMENT TO OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on April 10, 2017)
- AMENDMENT TO OVIDTHERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on April 10, 2017)
- OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on April 10, 2017)
